These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1114791)

  • 41. A, B and H blood group specificities in glycoprotein and glycolipid fractions of human erythrocyte membrane. Absence of blood group active glycoproteins in the membranes of non-secretors.
    Gardas A; Kościelak J
    Vox Sang; 1971 Feb; 20(2):137-49. PubMed ID: 5581701
    [No Abstract]   [Full Text] [Related]  

  • 42. The degradation of M and N blood group glycoproteins and glycopeptides with alkaline borohydride.
    Lisowska E
    Eur J Biochem; 1969 Oct; 10(3):574-9. PubMed ID: 5388499
    [No Abstract]   [Full Text] [Related]  

  • 43. [Sialic acid content and IgG binding of the glycocalyx of preserved erythrocytes].
    Halbhuber KJ; Feuerstein H; Fröber R; Stibenz D; Linss W; Geyer G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):382-8. PubMed ID: 89989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative isolation and purification of blood group-active glycosphingolipids from human B erythrocytes.
    Hanfland P; Egli H
    Vox Sang; 1975; 28(6):438-52. PubMed ID: 1146273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation of fucosyl glycoproteins from human erythrocyte membranes by affinity chromatography using Aleuria aurantia lectin.
    Yazawa S; Furukawa K; Kochibe N
    J Biochem; 1984 Dec; 96(6):1737-42. PubMed ID: 6530394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunochemical characterization of cyanogen bromide degradation products of M and N blood-group glycopeptides.
    Lisowska E; Waśniowska K
    Eur J Biochem; 1978 Jul; 88(1):247-52. PubMed ID: 668707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunobiology of the autoantibody response. II. The lipoprotein-associated soluble HB erythrocyte autoantigen of NZB mice.
    Linder E; Edgington TS
    J Immunol; 1973 Jan; 110(1):53-62. PubMed ID: 4119553
    [No Abstract]   [Full Text] [Related]  

  • 48. Localization of the binding sites for the Ricinus communis, Agaricus bisporus and wheat germ lectins on human erythrocyte membranes.
    Triche TJ; Tillack TW; Kornfeld S
    Biochim Biophys Acta; 1975 Jul; 394(4):540-9. PubMed ID: 1148231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunochemical comparison of human erythrocyte membrane proteins.
    Howe C; Blumenfeld OO; Lee LT; Copeland PC
    J Immunol; 1971 Apr; 106(4):1035-42. PubMed ID: 4994999
    [No Abstract]   [Full Text] [Related]  

  • 50. Spatial arrangement of some erythrocyte membrane receptor sites.
    Geyer G; Halbhuber KJ; Feuerstein H
    Acta Histochem; 1976; 55(2):317-24. PubMed ID: 823773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the N-linked glycopeptides of DQw1 and DR1 molecules.
    Iturbe S; Narasimhan S; Merrick JM; Falk JA; Letarte M
    J Immunol; 1986 Jun; 136(12):4588-95. PubMed ID: 3486905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly active amino-terminal sialoglycopenta-, hexa- and heptapeptides from human erythrocyte NM antigens.
    Springer GF; Yang HJ; Mbawa E; Grohlich D; Friedenson B
    Naturwissenschaften; 1980 Sep; 67(9):473-4. PubMed ID: 7422012
    [No Abstract]   [Full Text] [Related]  

  • 53. Structural and immunological studies on a sialoglycopeptide isolated from human urine.
    Lemonnier M; Bourrillon R
    Biochem Biophys Res Commun; 1975 May; 64(1):226-31. PubMed ID: 1170848
    [No Abstract]   [Full Text] [Related]  

  • 54. Heterogeneity of glycoproteins of the human erythrocyte membrane. Fractionation in sodium dodecyl sulfate containing solutions.
    Drzeniek Z; Lisowska E
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):263-70. PubMed ID: 444039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for erythrocyte membrane glycoproteins being carriers of blood-group P1 determinants.
    Haselberger CG; Schenkel-Brunner H
    FEBS Lett; 1982 Nov; 149(1):126-8. PubMed ID: 6185363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ASSOCIATION BETWEEN THE ERYTHROCYTE HEMAGGLUTINATION INHIBITOR AND THE M-N BLOOD GROUP SUBSTANCES.
    KATHAN RH; RIFF LJ; REAL M
    Proc Soc Exp Biol Med; 1963 Oct; 114():90-2. PubMed ID: 14076923
    [No Abstract]   [Full Text] [Related]  

  • 57. Blood group A and H determinants in polyglycosyl peptides of A1 and A2 erythrocytes.
    Viitala J; Finne J; Krusius T
    Eur J Biochem; 1982 Aug; 126(2):401-6. PubMed ID: 6181994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biosynthesis of the oligosaccharides of influenza viral glycoproteins.
    Nakamura N; Compans RW
    Virology; 1979 Feb; 93(1):31-47. PubMed ID: 433157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines.
    Wolf MF; Koerner U; Schumacher K
    Cancer Res; 1986 Apr; 46(4 Pt 1):1779-82. PubMed ID: 2418954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbohydrate-binding specificity of pokeweed mitogens.
    Yokoyama K; Terao T; Osawa T
    Biochim Biophys Acta; 1978 Jan; 538(2):384-96. PubMed ID: 620075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.